As of November 6, 2026, DiaMedica Therapeutics Inc. is a publicly traded company (Nasdaq: DMAC); its largest reported holder is Trill AB, with 16.9% on Schedule 13G/A of February 6, 2026, then TomEnterprise AB (16.28%) (Schedule 13G/A, February 6, 2026).
Is this your company?
About to sign with, pay or invest in DiaMedica Therapeutics Inc.? See the free Snapshot first.
Free to see. No signup.
Is DiaMedica Therapeutics Inc. a real, registered company?
- DiaMedica Therapeutics Inc. files with the SEC under CIK 1401040 (its SEC filings).
- Its shares are listed under the ticker DMAC on Nasdaq (SEC company record).
- Incorporated in Z4; business address in Minneapolis, Minnesota, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under DiaMedica Therapeutics Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Cooperman Leon G. (filed 2026-02-17).
Who are DiaMedica Therapeutics Inc.'s owners and officers?
DiaMedica Therapeutics Inc.: business address in Minneapolis, Minnesota; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-02-17).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2025-07-25)
- : Executive Officer (Form D, 2025-07-25)
- : Executive Officer (Form D, 2025-07-25)
- : Executive Officer (Form D, 2025-07-25)
- : Director (Form D, 2025-07-25)
- : Director (Form D, 2025-07-25)
- : Director (Form D, 2025-07-25)
- : Director (Form D, 2025-07-25)
- : Director (Form D, 2025-07-25)
- : Director (Form D, 2025-07-25)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-02-17 | Cooperman Leon G. | 6.6% |
| Schedule 13G/A, 2026-02-17 | John Fichthorn | 0.3% |
| Schedule 13G/A, 2026-02-06 | Trill Ab | 16.9% |
| Schedule 13G/A, 2025-11-07 | Richard Jacinto Ii | 9.6% |
| Schedule 13G/A, 2025-10-15 | Cooperman Leon G. | 6.3% |
| Schedule 13G/A, 2025-09-04 | Trill Ab | 15.02% |
| Schedule 13G, 2025-08-27 | Cooperman Leon G. | 6% |
| Schedule 13G/A, 2025-07-30 | Trill Ab | 13.14% |
| Schedule 13G/A, 2025-07-30 | Tomenterprise Ab | 16.28% |
Questions about who owns DiaMedica Therapeutics Inc.
Who owns DiaMedica Therapeutics Inc.?
On this page, 4 holders' latest ownership filings report 5% or more of DiaMedica Therapeutics Inc.: Trill Ab (16.9%, Schedule 13G/A, filed 2026-02-06), Tomenterprise Ab (16.28%, Schedule 13G/A, filed 2025-07-30), Richard Jacinto Ii (9.6%, Schedule 13G/A, filed 2025-11-07) and Cooperman Leon G. (6.6%, Schedule 13G/A, filed 2026-02-17).
Who are the largest shareholders of DiaMedica Therapeutics Inc.?
By the share each holder's latest filing reports, the largest holders of DiaMedica Therapeutics Inc. on this page are Trill Ab (16.9%), Tomenterprise Ab (16.28%) and Richard Jacinto Ii (9.6%).
When did Trill Ab buy into DiaMedica Therapeutics Inc.?
The filings give report dates, not purchase dates. The earliest filing from Trill Ab on this page is the Schedule 13G/A, filed 2025-07-30, reporting 13.14%; its latest, Schedule 13G/A filed 2026-02-06, reports 16.9%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 9 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on DiaMedica Therapeutics Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on DiaMedica Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on DiaMedica Therapeutics Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
16 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own DiaMedica Therapeutics Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a 10% owner: 8,825,742 shares (16.4% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2025-12-08).
- , a 10% owner: 8,825,742 shares (16.4% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2025-12-08).
- , a 10% owner: 8,383,577 shares (15.5% of shares outstanding), held indirectly through a see footnote 1, on a joint filing (Form 4, 2025-07-25).
- , a 10% owner: 8,383,577 shares (15.5% of shares outstanding), held indirectly through a see footnote 1, on a joint filing (Form 4, 2025-07-25).
- , a 10% owner: 8,383,577 shares (15.5% of shares outstanding), held indirectly through a see footnote 1, on a joint filing (Form 4, 2025-07-25).
Shares outstanding: 53,925,697 as of 2026-08-03, from the company's latest SEC cover page.
How much has DiaMedica Therapeutics Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-07-25 | $30.10M | $30.10M |
| Form D, 2024-07-02 | $11.80M | $11.80M |
| Form D, 2023-06-27 | $37.54M | $37.54M |
| Form D, 2023-04-18 | $750K | $750K |
Keep reading
More on DiaMedica Therapeutics Inc. and the records around it.
DiaMedica Therapeutics Inc. elsewhere on the record
- 5%+ stake filings Feb 2026
- Form D filing Jul 2025
Companies that share a holder
- Cooperman Leon G. also filed stake reports on 6 other companies: WhiteHawk Minerals Corp. (Aug 2026), Fidelis Insurance Holdings Ltd (Aug 2026), ASHLAND INC. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/diamedica-therapeutics